Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part I. Clinical overview and pathophysiology
Journal of the American Academy of Dermatology · 2024-07 · 91 (1) · 1-10
DOI: 10.1016/j.jaad.2023.08.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Academy of Dermatology, 2024-07. Verfasst von Hannah J Anderson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Thomas Jefferson University, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Pemphigus, Paraneoplastic Syndromes. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome (PNP/PAMS) is a highly fatal autoimmune blistering disease. The condition occurs in patients with underlying benign or malignant neoplasms, most commonly lymphoproliferative disorders. Both humoral and cell-mediated immunities contribute to the pathogenesis, and autoantibodies against plakin family proteins are characteristic. Patients typically present with severe stomatitis and polymorphous skin lesions, which are often resistant to treatment. Bronchiolitis obliterans (BO) is a frequent complication which contributes to the high mortality rate of PNP/PAMS. Given the rarity of this disorder and heterogeneity of clinical presentation, clinicians should maintain a high index of suspicion for PNP/PAMS to avoid delayed diagnosis. In this first part of a two-part continuing medical education (CME) series, risk factors, pathogenesis, and clinical features of PNP/PAMS are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Thomas Jefferson University, Philadelphia, Pennsylvania.
- Department of Dermatology, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: jason.lee@jefferson.edu.
Zitieren
APA
Anderson, H. J., Huang, S., & Lee, J. B. (2024). Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part I. Clinical overview and pathophysiology. Journal of the American Academy of Dermatology, 91(1), 1-10. https://doi.org/10.1016/j.jaad.2023.08.020
Vancouver
Anderson HJ, Huang S, Lee JB. Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part I. Clinical overview and pathophysiology. Journal of the American Academy of Dermatology. 2024;91(1):1-10. doi:10.1016/j.jaad.2023.08.020
BibTeX
@article{Anderson2024,
author = {Anderson, Hannah J and Huang, Simo and Lee, Jason B},
title = {Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part I. Clinical overview and pathophysiology},
journal = {Journal of the American Academy of Dermatology},
year = {2024},
volume = {91},
number = {1},
pages = {1--10},
doi = {10.1016/j.jaad.2023.08.020}
}
EUVIMED